Injectable Drug delivery Market – Global Industry Analysis and Forecast (2023-2029)


Injectable Drug delivery Market is expected to grow at a CAGR of 11.26% during the forecast period. Global Injectable Drug delivery Market is expected to reach US$ 1466.26 Bn. by 2029.

Injectable Drug delivery Market Overview

The increase in the prevalence of cancer and diabetes in recent years were the injectable drugs are used in the treatment and the current trend in developing the safety syringes, prefilled syringes, and auto-injectors are amplifying the market. Major factors obstructing the global injectable drug delivery market are the presence of alternatives to drug delivery procedures and safety concerns due to the increase in needle sticks during treatment. However, the increasing demand for generic injectable and bio similar is expected to generate new growth opportunities in the future for the injectable drug delivery market.Injectable Drug delivery Market

To know about the Research Methodology:-Request Free Sample Report

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

According to the World Health Organization (WHO), in 2014, the prevalence of diabetes over the age of 18 years has increased to xx%. According to the National Cancer Institute, cancer is considered as one of the prominent causes of death globally. Around xx Mn cancer-related deaths were reported in 2022 around the globe.

In terms of application, hormone disorders held the largest portion of the global market in 2022, owing to the growing frequency of hormonal disorders, such as diabetes.
Based on the end-user, the home care segment held the largest portion of the market, because of the high use of self-injectable pens and other devices at home majorly by diabetic patients.

Regional Insights

Region-wise, North America held the largest share of the global market in 2022 and is expected to endure leading over the forecast period as well. This can be attributed to the increasing incidences of diabetes and a growing aging population. According to the American Diabetes Association, more than US$ xx Mn people in the world and about US$ xx Mn people in the U.S. suffer from diabetes. Additionally, the increasing adoption of technically advanced drug delivery systems is anticipated to further boost the growth of North America regional market.

South American, Middle Eastern and African regions held the lowest shares of the market in 2022. Due to low awareness among the people about new technologies and lower affordability rates.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Injectable Drug Delivery Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Injectable Drug Delivery Market.

Injectable Drug delivery Market Scope : Inquire before buying






Global Injectable Drug delivery Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 694.76 Bn.




Forecast Period 2023 to 2029 CAGR:
11.26%
Market Size in 2029:
US $ 1466.26 Bn.




 Segments Covered:
by Type
Formulation
Conventional Drug Delivery
   Suspensions
   Solutions
   Lyophilized Formulations
   Emulsions
Novel Drug Delivery
   Long Acting Injection Formulation
    Microparticles
    Colloidal Dispersions
Others
Devices
Self-Injection Devices
   Needle-Free Injectors (NFI)
   Wearable Injectors
   Pen Injectors
   Auto-Injectors
   Others
Conventional Injection Devices
   Prefilled Syringes
   Fillable Syringes
   Others




by Applications
Autoimmune Diseases
Oncology Disorders
Hormonal Disorders
Orphan Diseases
Others




by End user
Home Care
Hospital
Ambulatory Care
Physician Offices or Clinics
Others






Injectable Drug delivery Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players :

1. Baxter International, Inc.,
2. Becton Dickinson and Company,
3. Gerresheimer AG,
4. Pfizer, Inc.,
5. Schott AG,
6. Alkermes Plc.,
7. Eli Lilly and Company,
8. Sandoz,
9. Terumo Corporation,
10. Teva Pharmaceuticals Industries Ltd.
11. Ypsomed,
12. Bespak
13. Unilife Corporation
14. Vetter Pharma-Fertigung GmbH & Co. KG
15. BD
16. SHL Medical AG
17. West Pharmaceutical Services, Inc.
18. Insulate Corporation
19. Elcam Medical
20. B. Braun Melsungen
21. Mylan N.V.
22. Diabnext
23. Biocon
24. Antares Pharma
25. AbbVie Inc.
26. Diabnext
27. SiO2 Medical Products

Frequently Asked Questions:

1. Which region has the largest share in Global Injectable Drug delivery Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Injectable Drug delivery Market?
Ans: The Global Market is expected to grow at a CAGR of 11.26% during forecast period 2023-2029.

3. What is scope of the Global Injectable Drug delivery market report?
Ans: Global Injectable Drug delivery Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Injectable Drug delivery market?
Ans: The important key players in the Global Market are – Denso Corporation, Hanon Systems, Sanden Holding Corporation, Mitsubishi Heavy Industries Ltd, MAHLE GmbH, Valeo SA, Keihin Corporation, Calsonic Kansei Corporation, Samvardhana Motherson Group, Subros Limited, SMAC Auto Air, TransAir Manufacturing, Eberspacher Group, Marelli Corporation.

5. What is the study period of this market?
Ans: The Global Injectable Drug delivery Market is studied from 2022 to 2029. 





Global Injectable Drug Delivery Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Injectable Drug Delivery Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Injectable Drug Delivery Market Analysis and Forecast
6.1. Global Injectable Drug Delivery Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Injectable Drug Delivery Market Analysis and Forecast, by Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Injectable Drug Delivery Market Value Share Analysis, by Type
7.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Type
7.5. Global Injectable Drug Delivery Market Analysis, by Type
7.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by Type

8. Global Injectable Drug Delivery Market Analysis and Forecast, by End User
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Injectable Drug Delivery Market Value Share Analysis, by End User
8.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by End User
8.5. Global Injectable Drug Delivery Market Analysis, by End User
8.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by End User

9. Global Injectable Drug Delivery Market Analysis and Forecast, by Application
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Injectable Drug Delivery Market Value Share Analysis, by Application
9.4. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Application
9.5. Global Injectable Drug Delivery Market Analysis, by Application
9.6. Global Injectable Drug Delivery Market Attractiveness Analysis, by Application

10. Global Injectable Drug Delivery Market Analysis, by Region
10.1. Global Injectable Drug Delivery Market Value Share Analysis, by Region
10.2. Global Injectable Drug Delivery Market Size (US$ Bn) Forecast, by Region
10.3. Global Injectable Drug Delivery Market Attractiveness Analysis, by Region

11. North America Injectable Drug Delivery Market Analysis
11.1. Key Findings
11.2. North America Injectable Drug Delivery Market Overview
11.3. North America Injectable Drug Delivery Market Value Share Analysis, by Type
11.4. North America Injectable Drug Delivery Market Forecast, by Type
11.4.1. Formulation
11.4.1.1. Conventional Drug Delivery
11.4.1.1.1. Suspensions
11.4.1.1.2. Solutions
11.4.1.1.3. Lyophilized Formulations
11.4.1.1.4. Emulsions
11.4.1.2. Novel Drug Delivery
11.4.1.2.1. Long Acting Injection Formulation
11.4.1.2.2. Microparticles
11.4.1.2.3. Colloidal Dispersions
11.4.1.3. Others
11.4.2. Devices
11.4.2.1. Self-Injection Devices
11.4.2.1.1. Needle-Free Injectors (NFI)
11.4.2.1.2. Wearable Injectors
11.4.2.1.3. Pen Injectors
11.4.2.1.4. Auto-Injectors
11.4.2.1.5. Others
11.4.3. Conventional Injection Devices
11.4.3.1.1. Prefilled Syringes
11.4.3.1.2. Fillable Syringes
11.4.3.1.3. Others
11.5. North America Injectable Drug Delivery Market Value Share Analysis, by End User
11.6. North America Injectable Drug Delivery Market Forecast, by End User
11.6.1. Home Care
11.6.2. Hospital
11.6.3. Ambulatory Care
11.6.4. Physician Offices or Clinics
11.6.5. Others
11.7. North America Injectable Drug Delivery Market Value Share Analysis, by Application
11.8. North America Injectable Drug Delivery Market Forecast, by Application
11.8.1.1. Autoimmune Diseases
11.8.1.2. Oncology Disorders
11.8.1.3. Hormonal Disorders
11.8.1.4. Orphan Diseases
11.8.1.5. Others
11.9. North America Injectable Drug Delivery Market Value Share Analysis, by Country
11.10. North America Injectable Drug Delivery Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Injectable Drug Delivery Market Analysis, by Country
11.12. U.S. Injectable Drug Delivery Market Forecast, by Type
11.12.1. Formulation
11.12.1.1. Conventional Drug Delivery
11.12.1.1.1. Suspensions
11.12.1.1.2. Solutions
11.12.1.1.3. Lyophilized Formulations
11.12.1.1.4. Emulsions
11.12.1.2. Novel Drug Delivery
11.12.1.2.1. Long Acting Injection Formulation
11.12.1.2.2. Microparticles
11.12.1.2.3. Colloidal Dispersions
11.12.1.3. Others
11.12.2. Devices
11.12.2.1. Self-Injection Devices
11.12.2.1.1. Needle-Free Injectors (NFI)
11.12.2.1.2. Wearable Injectors
11.12.2.1.3. Pen Injectors
11.12.2.1.4. Auto-Injectors
11.12.2.1.5. Others
11.12.3. Conventional Injection Devices
11.12.3.1.1. Prefilled Syringes
11.12.3.1.2. Fillable Syringes
11.12.3.1.3. Others
11.13. U.S. Injectable Drug Delivery Market Forecast, by End User
11.13.1. Home Care
11.13.2. Hospital
11.13.3. Ambulatory Care
11.13.4. Physician Offices or Clinics
11.13.5. Others
11.14. U.S. Injectable Drug Delivery Market Forecast, by Application
11.14.1.1. Autoimmune Diseases
11.14.1.2. Oncology Disorders
11.14.1.3. Hormonal Disorders
11.14.1.4. Orphan Diseases
11.14.1.5. Others
11.15. Canada Injectable Drug Delivery Market Forecast, by Type
11.15.1. Formulation
11.15.1.1. Conventional Drug Delivery
11.15.1.1.1. Suspensions
11.15.1.1.2. Solutions
11.15.1.1.3. Lyophilized Formulations
11.15.1.1.4. Emulsions
11.15.1.2. Novel Drug Delivery
11.15.1.2.1. Long Acting Injection Formulation
11.15.1.2.2. Microparticles
11.15.1.2.3. Colloidal Dispersions
11.15.1.3. Others
11.15.2. Devices
11.15.2.1. Self-Injection Devices
11.15.2.1.1. Needle-Free Injectors (NFI)
11.15.2.1.2. Wearable Injectors
11.15.2.1.3. Pen Injectors
11.15.2.1.4. Auto-Injectors
11.15.2.1.5. Others
11.15.3. Conventional Injection Devices
11.15.3.1.1. Prefilled Syringes
11.15.3.1.2. Fillable Syringes
11.15.3.1.3. Others
11.16. Steel Canada Injectable Drug Delivery Market Forecast, by End User
11.16.1. Home Care
11.16.2. Hospital
11.16.3. Ambulatory Care
11.16.4. Physician Offices or Clinics
11.17. Others Canada Injectable Drug Delivery Market Forecast, by Application
11.17.1.1. Autoimmune Diseases
11.17.1.2. Oncology Disorders
11.17.1.3. Hormonal Disorders
11.17.1.4. Orphan Diseases
11.17.1.5. Others
11.18. North America Injectable Drug Delivery Market Attractiveness Analysis
11.18.1. By Type
11.18.2. By End User
11.18.3. By Application
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Injectable Drug Delivery Market Analysis
12.1. Key Findings
12.2. Europe Injectable Drug Delivery Market Overview
12.3. Europe Injectable Drug Delivery Market Value Share Analysis, by Type
12.4. Europe Injectable Drug Delivery Market Forecast, by Type
12.4.1. Formulation
12.4.1.1. Conventional Drug Delivery
12.4.1.1.1. Suspensions
12.4.1.1.2. Solutions
12.4.1.1.3. Lyophilized Formulations
12.4.1.1.4. Emulsions
12.4.1.2. Novel Drug Delivery
12.4.1.2.1. Long Acting Injection Formulation
12.4.1.2.2. Microparticles
12.4.1.2.3. Colloidal Dispersions
12.4.1.3. Others
12.4.2. Devices
12.4.2.1. Self-Injection Devices
12.4.2.1.1. Needle-Free Injectors (NFI)
12.4.2.1.2. Wearable Injectors
12.4.2.1.3. Pen Injectors
12.4.2.1.4. Auto-Injectors
12.4.2.1.5. Others
12.4.3. Conventional Injection Devices
12.4.3.1.1. Prefilled Syringes
12.4.3.1.2. Fillable Syringes
12.4.3.1.3. Others
12.5. Europe Injectable Drug Delivery Market Value Share Analysis, by End User
12.6. Europe Injectable Drug Delivery Market Forecast, by End User
12.6.1. Home Care
12.6.2. Hospital
12.6.3. Ambulatory Care
12.6.4. Physician Offices or Clinics
12.6.5. Others
12.7. Europe Injectable Drug Delivery Market Value Share Analysis, by Application
12.8. Europe Injectable Drug Delivery Market Forecast, by Application
12.8.1.1. Autoimmune Diseases
12.8.1.2. Oncology Disorders
12.8.1.3. Hormonal Disorders
12.8.1.4. Orphan Diseases
12.8.1.5. Others
12.9. Europe Injectable Drug Delivery Market Value Share Analysis, by Country
12.10. Europe Injectable Drug Delivery Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Injectable Drug Delivery Market Analysis, by Country
12.12. Germany Injectable Drug Delivery Market Forecast, by Type
12.12.1. Formulation
12.12.1.1. Conventional Drug Delivery
12.12.1.1.1. Suspensions
12.12.1.1.2. Solutions
12.12.1.1.3. Lyophilized Formulations
12.12.1.1.4. Emulsions
12.12.1.2. Novel Drug Delivery
12.12.1.2.1. Long Acting Injection Formulation
12.12.1.2.2. Microparticles
12.12.1.2.3. Colloidal Dispersions
12.12.1.3. Others
12.12.2. Devices
12.12.2.1. Self-Injection Devices
12.12.2.1.1. Needle-Free Injectors (NFI)
12.12.2.1.2. Wearable Injectors
12.12.2.1.3. Pen Injectors
12.12.2.1.4. Auto-Injectors
12.12.2.1.5. Others
12.12.3. Conventional Injection Devices
12.12.3.1.1. Prefilled Syringes
12.12.3.1.2. Fillable Syringes
12.12.3.1.3. Others
12.13. Germany Injectable Drug Delivery Market Forecast, by End User
12.13.1. Home Care
12.13.2. Hospital
12.13.3. Ambulatory Care
12.13.4. Physician Offices or Clinics
12.13.5. Others
12.14. Germany Injectable Drug Delivery Market Forecast, by Application
12.14.1.1. Autoimmune Diseases
12.14.1.2. Oncology Disorders
12.14.1.3. Hormonal Disorders
12.14.1.4. Orphan Diseases
12.14.1.5. Others
12.15. U.K. Injectable Drug Delivery Market Forecast, by Type
12.15.1. Formulation
12.15.1.1. Conventional Drug Delivery
12.15.1.1.1. Suspensions
12.15.1.1.2. Solutions
12.15.1.1.3. Lyophilized Formulations
12.15.1.1.4. Emulsions
12.15.1.2. Novel Drug Delivery
12.15.1.2.1. Long Acting Injection Formulation
12.15.1.2.2. Microparticles
12.15.1.2.3. Colloidal Dispersions
12.15.1.3. Others
12.15.2. Devices
12.15.2.1. Self-Injection Devices
12.15.2.1.1. Needle-Free Injectors (NFI)
12.15.2.1.2. Wearable Injectors
12.15.2.1.3. Pen Injectors
12.15.2.1.4. Auto-Injectors
12.15.2.1.5. Others
12.15.3. Conventional Injection Devices
12.15.3.1.1. Prefilled Syringes
12.15.3.1.2. Fillable Syringes
12.15.3.1.3. Others
12.16. U.K. Injectable Drug Delivery Market Forecast, by End User
12.16.1. Home Care
12.16.2. Hospital
12.16.3. Ambulatory Care
12.16.4. Physician Offices or Clinics
12.16.5. Others
12.17. U.K. Injectable Drug Delivery Market Forecast, by Application
12.17.1.1. Autoimmune Diseases
12.17.1.2. Oncology Disorders
12.17.1.3. Hormonal Disorders
12.17.1.4. Orphan Diseases
12.17.1.5. Others
12.18. France Injectable Drug Delivery Market Forecast, by Type
12.18.1. Formulation
12.18.1.1. Conventional Drug Delivery
12.18.1.1.1. Suspensions
12.18.1.1.2. Solutions
12.18.1.1.3. Lyophilized Formulations
12.18.1.1.4. Emulsions
12.18.1.2. Novel Drug Delivery
12.18.1.2.1. Long Acting Injection Formulation
12.18.1.2.2. Microparticles
12.18.1.2.3. Colloidal Dispersions
12.18.1.3. Others
12.18.2. Devices
12.18.2.1. Self-Injection Devices
12.18.2.1.1. Needle-Free Injectors (NFI)
12.18.2.1.2. Wearable Injectors
12.18.2.1.3. Pen Injectors
12.18.2.1.4. Auto-Injectors
12.18.2.1.5. Others
12.18.3. Conventional Injection Devices
12.18.3.1.1. Prefilled Syringes
12.18.3.1.2. Fillable Syringes
12.18.3.1.3. Others
12.19. France Injectable Drug Delivery Market Forecast, by End User
12.19.1. Home Care
12.19.2. Hospital
12.19.3. Ambulatory Care
12.19.4. Physician Offices or Clinics
12.19.5. Others
12.20. France Injectable Drug Delivery Market Forecast, by Application
12.20.1.1. Autoimmune Diseases
12.20.1.2. Oncology Disorders
12.20.1.3. Hormonal Disorders
12.20.1.4. Orphan Diseases
12.20.1.5. Others
12.21. Italy Injectable Drug Delivery Market Forecast, by Type
12.21.1. Formulation
12.21.1.1. Conventional Drug Delivery
12.21.1.1.1. Suspensions
12.21.1.1.2. Solutions
12.21.1.1.3. Lyophilized Formulations
12.21.1.1.4. Emulsions
12.21.1.2. Novel Drug Delivery
12.21.1.2.1. Long Acting Injection Formulation
12.21.1.2.2. Microparticles
12.21.1.2.3. Colloidal Dispersions
12.21.1.3. Others
12.21.2. Devices
12.21.2.1. Self-Injection Devices
12.21.2.1.1. Needle-Free Injectors (NFI)
12.21.2.1.2. Wearable Injectors
12.21.2.1.3. Pen Injectors
12.21.2.1.4. Auto-Injectors
12.21.2.1.5. Others
12.21.3. Conventional Injection Devices
12.21.3.1.1. Prefilled Syringes
12.21.3.1.2. Fillable Syringes
12.21.3.1.3. Others
12.22. Italy Injectable Drug Delivery Market Forecast, by End User
12.22.1. Home Care
12.22.2. Hospital
12.22.3. Ambulatory Care
12.22.4. Physician Offices or Clinics
12.22.5. Others
12.23. Italy Injectable Drug Delivery Market Forecast, by Application
12.23.1.1. Autoimmune Diseases
12.23.1.2. Oncology Disorders
12.23.1.3. Hormonal Disorders
12.23.1.4. Orphan Diseases
12.23.1.5. Others
12.24. Spain Injectable Drug Delivery Market Forecast, by Type
12.24.1. Formulation
12.24.1.1. Conventional Drug Delivery
12.24.1.1.1. Suspensions
12.24.1.1.2. Solutions
12.24.1.1.3. Lyophilized Formulations
12.24.1.1.4. Emulsions
12.24.1.2. Novel Drug Delivery
12.24.1.2.1. Long Acting Injection Formulation
12.24.1.2.2. Microparticles
12.24.1.2.3. Colloidal Dispersions
12.24.1.3. Others
12.24.2. Devices
12.24.2.1. Self-Injection Devices
12.24.2.1.1. Needle-Free Injectors (NFI)
12.24.2.1.2. Wearable Injectors
12.24.2.1.3. Pen Injectors
12.24.2.1.4. Auto-Injectors
12.24.2.1.5. Others
12.24.3. Conventional Injection Devices
12.24.3.1.1. Prefilled Syringes
12.24.3.1.2. Fillable Syringes
12.24.3.1.3. Others
12.25. Spain Injectable Drug Delivery Market Forecast, by End User
12.25.1. Home Care
12.25.2. Hospital
12.25.3. Ambulatory Care
12.25.4. Physician Offices or Clinics
12.25.5. Others
12.26. Spain Injectable Drug Delivery Market Forecast, by Application
12.26.1.1. Autoimmune Diseases
12.26.1.2. Oncology Disorders
12.26.1.3. Hormonal Disorders
12.26.1.4. Orphan Diseases
12.26.1.5. Others
12.27. Rest of Europe Injectable Drug Delivery Market Forecast, by Type
12.27.1. Formulation
12.27.1.1. Conventional Drug Delivery
12.27.1.1.1. Suspensions
12.27.1.1.2. Solutions
12.27.1.1.3. Lyophilized Formulations
12.27.1.1.4. Emulsions
12.27.1.2. Novel Drug Delivery
12.27.1.2.1. Long Acting Injection Formulation
12.27.1.2.2. Microparticles
12.27.1.2.3. Colloidal Dispersions
12.27.1.3. Others
12.27.2. Devices
12.27.2.1. Self-Injection Devices
12.27.2.1.1. Needle-Free Injectors (NFI)
12.27.2.1.2. Wearable Injectors
12.27.2.1.3. Pen Injectors
12.27.2.1.4. Auto-Injectors
12.27.2.1.5. Others
12.27.3. Conventional Injection Devices
12.27.3.1.1. Prefilled Syringes
12.27.3.1.2. Fillable Syringes
12.27.3.1.3. Others
12.28. Rest of Europe Injectable Drug Delivery Market Forecast, by End User
12.28.1. Home Care
12.28.2. Hospital
12.28.3. Ambulatory Care
12.28.4. Physician Offices or Clinics
12.28.5. Others
12.29. Rest Of Europe Injectable Drug Delivery Market Forecast, by Application
12.29.1.1. Autoimmune Diseases
12.29.1.2. Oncology Disorders
12.29.1.3. Hormonal Disorders
12.29.1.4. Orphan Diseases
12.29.1.5. Others
12.30. Europe Injectable Drug Delivery Market Attractiveness Analysis
12.30.1. By Type
12.30.2. By End User
12.30.3. By Application
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments

13. Asia Pacific Injectable Drug Delivery Market Analysis
13.1. Key Findings
13.2. Asia Pacific Injectable Drug Delivery Market Overview
13.3. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Type
13.4. Asia Pacific Injectable Drug Delivery Market Forecast, by Type
13.4.1. Formulation
13.4.1.1. Conventional Drug Delivery
13.4.1.1.1. Suspensions
13.4.1.1.2. Solutions
13.4.1.1.3. Lyophilized Formulations
13.4.1.1.4. Emulsions
13.4.1.2. Novel Drug Delivery
13.4.1.2.1. Long Acting Injection Formulation
13.4.1.2.2. Microparticles
13.4.1.2.3. Colloidal Dispersions
13.4.1.3. Others
13.4.2. Devices
13.4.2.1. Self-Injection Devices
13.4.2.1.1. Needle-Free Injectors (NFI)
13.4.2.1.2. Wearable Injectors
13.4.2.1.3. Pen Injectors
13.4.2.1.4. Auto-Injectors
13.4.2.1.5. Others
13.4.3. Conventional Injection Devices
13.4.3.1.1. Prefilled Syringes
13.4.3.1.2. Fillable Syringes
13.4.3.1.3. Others
13.5. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by End User
13.6. Asia Pacific Injectable Drug Delivery Market Forecast, by End User
13.6.1. Home Care
13.6.2. Hospital
13.6.3. Ambulatory Care
13.6.4. Physician Offices or Clinics
13.6.5. Others
13.7. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Application
13.8. Asia Pacific Injectable Drug Delivery Market Forecast, by Application
13.8.1.1. Autoimmune Diseases
13.8.1.2. Oncology Disorders
13.8.1.3. Hormonal Disorders
13.8.1.4. Orphan Diseases
13.8.1.5. Others
13.9. Asia Pacific Injectable Drug Delivery Market Value Share Analysis, by Country
13.10. Asia Pacific Injectable Drug Delivery Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Injectable Drug Delivery Market Analysis, by Country
13.12. China Injectable Drug Delivery Market Forecast, by Type
13.12.1. Formulation
13.12.1.1. Conventional Drug Delivery
13.12.1.1.1. Suspensions
13.12.1.1.2. Solutions
13.12.1.1.3. Lyophilized Formulations
13.12.1.1.4. Emulsions
13.12.1.2. Novel Drug Delivery
13.12.1.2.1. Long Acting Injection Formulation
13.12.1.2.2. Microparticles
13.12.1.2.3. Colloidal Dispersions
13.12.1.3. Others
13.12.2. Devices
13.12.2.1. Self-Injection Devices
13.12.2.1.1. Needle-Free Injectors (NFI)
13.12.2.1.2. Wearable Injectors
13.12.2.1.3. Pen Injectors
13.12.2.1.4. Auto-Injectors
13.12.2.1.5. Others
13.12.3. Conventional Injection Devices
13.12.3.1.1. Prefilled Syringes
13.12.3.1.2. Fillable Syringes
13.12.3.1.3. Others
13.13. China Injectable Drug Delivery Market Forecast, by End User
13.13.1. Home Care
13.13.2. Hospital
13.13.3. Ambulatory Care
13.13.4. Physician Offices or Clinics
13.13.5. Others
13.14. China Injectable Drug Delivery Market Forecast, by Application
13.14.1.1. Autoimmune Diseases
13.14.1.2. Oncology Disorders
13.14.1.3. Hormonal Disorders
13.14.1.4. Orphan Diseases
13.14.1.5. Others
13.15. India Injectable Drug Delivery Market Forecast, by Type
13.15.1. Formulation
13.15.1.1. Conventional Drug Delivery
13.15.1.1.1. Suspensions
13.15.1.1.2. Solutions
13.15.1.1.3. Lyophilized Formulations
13.15.1.1.4. Emulsions
13.15.1.2. Novel Drug Delivery
13.15.1.2.1. Long Acting Injection Formulation
13.15.1.2.2. Microparticles
13.15.1.2.3. Colloidal Dispersions
13.15.1.3. Others
13.15.2. Devices
13.15.2.1. Self-Injection Devices
13.15.2.1.1. Needle-Free Injectors (NFI)
13.15.2.1.2. Wearable Injectors
13.15.2.1.3. Pen Injectors
13.15.2.1.4. Auto-Injectors
13.15.2.1.5. Others
13.15.3. Conventional Injection Devices
13.15.3.1.1. Prefilled Syringes
13.15.3.1.2. Fillable Syringes
13.15.3.1.3. Others
13.16. India Injectable Drug Delivery Market Forecast, by End User
13.16.1. Home Care
13.16.2. Hospital
13.16.3. Ambulatory Care
13.16.4. Physician Offices or Clinics
13.16.5. Others
13.17. India Injectable Drug Delivery Market Forecast, by Application
13.17.1.1. Autoimmune Diseases
13.17.1.2. Oncology Disorders
13.17.1.3. Hormonal Disorders
13.17.1.4. Orphan Diseases
13.17.1.5. Others
13.18. Japan Injectable Drug Delivery Market Forecast, by Type
13.18.1. Formulation
13.18.1.1. Conventional Drug Delivery
13.18.1.1.1. Suspensions
13.18.1.1.2. Solutions
13.18.1.1.3. Lyophilized Formulations
13.18.1.1.4. Emulsions
13.18.1.2. Novel Drug Delivery
13.18.1.2.1. Long Acting Injection Formulation
13.18.1.2.2. Microparticles
13.18.1.2.3. Colloidal Dispersions
13.18.1.3. Others
13.18.2. Devices
13.18.2.1. Self-Injection Devices
13.18.2.1.1. Needle-Free Injectors (NFI)
13.18.2.1.2. Wearable Injectors
13.18.2.1.3. Pen Injectors
13.18.2.1.4. Auto-Injectors
13.18.2.1.5. Others
13.18.3. Conventional Injection Devices
13.18.3.1.1. Prefilled Syringes
13.18.3.1.2. Fillable Syringes
13.18.3.1.3. Others
13.19. Japan Injectable Drug Delivery Market Forecast, by End User
13.19.1. Home Care
13.19.2. Hospital
13.19.3. Ambulatory Care
13.19.4. Physician Offices or Clinics
13.19.5. Others
13.20. Japan Injectable Drug Delivery Market Forecast, by Application
13.20.1.1. Autoimmune Diseases
13.20.1.2. Oncology Disorders
13.20.1.3. Hormonal Disorders
13.20.1.4. Orphan Diseases
13.20.1.5. Others
13.21. ASEAN Injectable Drug Delivery Market Forecast, by Type
13.21.1. Formulation
13.21.1.1. Conventional Drug Delivery
13.21.1.1.1. Suspensions
13.21.1.1.2. Solutions
13.21.1.1.3. Lyophilized Formulations
13.21.1.1.4. Emulsions
13.21.1.2. Novel Drug Delivery
13.21.1.2.1. Long Acting Injection Formulation
13.21.1.2.2. Microparticles
13.21.1.2.3. Colloidal Dispersions
13.21.1.3. Others
13.21.2. Devices
13.21.2.1. Self-Injection Devices
13.21.2.1.1. Needle-Free Injectors (NFI)
13.21.2.1.2. Wearable Injectors
13.21.2.1.3. Pen Injectors
13.21.2.1.4. Auto-Injectors
13.21.2.1.5. Others
13.21.3. Conventional Injection Devices
13.21.3.1.1. Prefilled Syringes
13.21.3.1.2. Fillable Syringes
13.21.3.1.3. Others
13.22. ASEAN Injectable Drug Delivery Market Forecast, by End User
13.22.1. Home Care
13.22.2. Hospital
13.22.3. Ambulatory Care
13.22.4. Physician Offices or Clinics
13.22.5. Others
13.23. ASEAN Injectable Drug Delivery Market Forecast, by Application
13.23.1.1. Autoimmune Diseases
13.23.1.2. Oncology Disorders
13.23.1.3. Hormonal Disorders
13.23.1.4. Orphan Diseases
13.23.1.5. Others
13.24. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by Type
13.24.1. Formulation
13.24.1.1. Conventional Drug Delivery
13.24.1.1.1. Suspensions
13.24.1.1.2. Solutions
13.24.1.1.3. Lyophilized Formulations
13.24.1.1.4. Emulsions
13.24.1.2. Novel Drug Delivery
13.24.1.2.1. Long Acting Injection Formulation
13.24.1.2.2. Microparticles
13.24.1.2.3. Colloidal Dispersions
13.24.1.3. Others
13.24.2. Devices
13.24.2.1. Self-Injection Devices
13.24.2.1.1. Needle-Free Injectors (NFI)
13.24.2.1.2. Wearable Injectors
13.24.2.1.3. Pen Injectors
13.24.2.1.4. Auto-Injectors
13.24.2.1.5. Others
13.24.3. Conventional Injection Devices
13.24.3.1.1. Prefilled Syringes
13.24.3.1.2. Fillable Syringes
13.24.3.1.3. Others
13.25. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by End User
13.25.1. Home Care
13.25.2. Hospital
13.25.3. Ambulatory Care
13.25.4. Physician Offices or Clinics
13.25.5. Others
13.26. Rest of Asia Pacific Injectable Drug Delivery Market Forecast, by Application
13.26.1.1. Autoimmune Diseases
13.26.1.2. Oncology Disorders
13.26.1.3. Hormonal Disorders
13.26.1.4. Orphan Diseases
13.26.1.5. Others
13.27. Asia Pacific Injectable Drug Delivery Market Attractiveness Analysis
13.27.1. By Type
13.27.2. By End User
13.27.3. By Application
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments

14. Middle East & Africa Injectable Drug Delivery Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Injectable Drug Delivery Market Overview
14.3. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Type
14.4. Middle East & Africa Injectable Drug Delivery Market Forecast, by Type
14.4.1. Formulation
14.4.1.1. Conventional Drug Delivery
14.4.1.1.1. Suspensions
14.4.1.1.2. Solutions
14.4.1.1.3. Lyophilized Formulations
14.4.1.1.4. Emulsions
14.4.1.2. Novel Drug Delivery
14.4.1.2.1. Long Acting Injection Formulation
14.4.1.2.2. Microparticles
14.4.1.2.3. Colloidal Dispersions
14.4.1.3. Others
14.4.2. Devices
14.4.2.1. Self-Injection Devices
14.4.2.1.1. Needle-Free Injectors (NFI)
14.4.2.1.2. Wearable Injectors
14.4.2.1.3. Pen Injectors
14.4.2.1.4. Auto-Injectors
14.4.2.1.5. Others
14.4.3. Conventional Injection Devices
14.4.3.1.1. Prefilled Syringes
14.4.3.1.2. Fillable Syringes
14.4.3.1.3. Others
14.5. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by End User
14.6. Middle East & Africa Injectable Drug Delivery Market Forecast, by End User
14.6.1. Home Care
14.6.2. Hospital
14.6.3. Ambulatory Care
14.6.4. Physician Offices or Clinics
14.6.5. Others
14.7. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Application
14.8. Middle East & Africa Injectable Drug Delivery Market Forecast, by Application
14.8.1.1. Autoimmune Diseases
14.8.1.2. Oncology Disorders
14.8.1.3. Hormonal Disorders
14.8.1.4. Orphan Diseases
14.8.1.5. Others
14.9. Middle East & Africa Injectable Drug Delivery Market Value Share Analysis, by Country
14.10. Middle East & Africa Injectable Drug Delivery Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Injectable Drug Delivery Market Analysis, by Country
14.12. GCC Injectable Drug Delivery Market Forecast, by Type
14.12.1. Formulation
14.12.1.1. Conventional Drug Delivery
14.12.1.1.1. Suspensions
14.12.1.1.2. Solutions
14.12.1.1.3. Lyophilized Formulations
14.12.1.1.4. Emulsions
14.12.1.2. Novel Drug Delivery
14.12.1.2.1. Long Acting Injection Formulation
14.12.1.2.2. Microparticles
14.12.1.2.3. Colloidal Dispersions
14.12.1.3. Others
14.12.2. Devices
14.12.2.1. Self-Injection Devices
14.12.2.1.1. Needle-Free Injectors (NFI)
14.12.2.1.2. Wearable Injectors
14.12.2.1.3. Pen Injectors
14.12.2.1.4. Auto-Injectors
14.12.2.1.5. Others
14.12.3. Conventional Injection Devices
14.12.3.1.1. Prefilled Syringes
14.12.3.1.2. Fillable Syringes
14.12.3.1.3. Others
14.13. GCC Injectable Drug Delivery Market Forecast, by End User
14.13.1. Home Care
14.13.2. Hospital
14.13.3. Ambulatory Care
14.13.4. Physician Offices or Clinics
14.13.5. Others
14.14. GCC Injectable Drug Delivery Market Forecast, by Application
14.14.1.1. Autoimmune Diseases
14.14.1.2. Oncology Disorders
14.14.1.3. Hormonal Disorders
14.14.1.4. Orphan Diseases
14.14.1.5. Others
14.15. South Africa Injectable Drug Delivery Market Forecast, by Type
14.15.1. Formulation
14.15.1.1. Conventional Drug Delivery
14.15.1.1.1. Suspensions
14.15.1.1.2. Solutions
14.15.1.1.3. Lyophilized Formulations
14.15.1.1.4. Emulsions
14.15.1.2. Novel Drug Delivery
14.15.1.2.1. Long Acting Injection Formulation
14.15.1.2.2. Microparticles
14.15.1.2.3. Colloidal Dispersions
14.15.1.3. Others
14.15.2. Devices
14.15.2.1. Self-Injection Devices
14.15.2.1.1. Needle-Free Injectors (NFI)
14.15.2.1.2. Wearable Injectors
14.15.2.1.3. Pen Injectors
14.15.2.1.4. Auto-Injectors
14.15.2.1.5. Others
14.15.3. Conventional Injection Devices
14.15.3.1.1. Prefilled Syringes
14.15.3.1.2. Fillable Syringes
14.15.3.1.3. Others
14.16. South Africa Injectable Drug Delivery Market Forecast, by End User
14.16.1. Home Care
14.16.2. Hospital
14.16.3. Ambulatory Care
14.16.4. Physician Offices or Clinics
14.16.5. Others
14.17. South Africa Injectable Drug Delivery Market Forecast, by Application
14.17.1.1. Autoimmune Diseases
14.17.1.2. Oncology Disorders
14.17.1.3. Hormonal Disorders
14.17.1.4. Orphan Diseases
14.17.1.5. Others
14.18. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by Type
14.18.1. Formulation
14.18.1.1. Conventional Drug Delivery
14.18.1.1.1. Suspensions
14.18.1.1.2. Solutions
14.18.1.1.3. Lyophilized Formulations
14.18.1.1.4. Emulsions
14.18.1.2. Novel Drug Delivery
14.18.1.2.1. Long Acting Injection Formulation
14.18.1.2.2. Microparticles
14.18.1.2.3. Colloidal Dispersions
14.18.1.3. Others
14.18.2. Devices
14.18.2.1. Self-Injection Devices
14.18.2.1.1. Needle-Free Injectors (NFI)
14.18.2.1.2. Wearable Injectors
14.18.2.1.3. Pen Injectors
14.18.2.1.4. Auto-Injectors
14.18.2.1.5. Others
14.18.3. Conventional Injection Devices
14.18.3.1.1. Prefilled Syringes
14.18.3.1.2. Fillable Syringes
14.18.3.1.3. Others
14.19. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by End User
14.19.1. Home Care
14.19.2. Hospital
14.19.3. Ambulatory Care
14.19.4. Physician Offices or Clinics
14.19.5. Others
14.20. Rest of Middle East & Africa Injectable Drug Delivery Market Forecast, by Application
14.20.1.1. Autoimmune Diseases
14.20.1.2. Oncology Disorders
14.20.1.3. Hormonal Disorders
14.20.1.4. Orphan Diseases
14.20.1.5. Others
14.21. Middle East & Africa Injectable Drug Delivery Market Attractiveness Analysis
14.21.1. By Type
14.21.2. By End User
14.21.3. By Application
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Injectable Drug Delivery Market Analysis
15.1. Key Findings
15.2. South America Injectable Drug Delivery Market Overview
15.3. South America Injectable Drug Delivery Market Value Share Analysis, by Type
15.4. South America Injectable Drug Delivery Market Forecast, by Type
15.4.1. Formulation
15.4.1.1. Conventional Drug Delivery
15.4.1.1.1. Suspensions
15.4.1.1.2. Solutions
15.4.1.1.3. Lyophilized Formulations
15.4.1.1.4. Emulsions
15.4.1.2. Novel Drug Delivery
15.4.1.2.1. Long Acting Injection Formulation
15.4.1.2.2. Microparticles
15.4.1.2.3. Colloidal Dispersions
15.4.1.3. Others
15.4.2. Devices
15.4.2.1. Self-Injection Devices
15.4.2.1.1. Needle-Free Injectors (NFI)
15.4.2.1.2. Wearable Injectors
15.4.2.1.3. Pen Injectors
15.4.2.1.4. Auto-Injectors
15.4.2.1.5. Others
15.4.3. Conventional Injection Devices
15.4.3.1.1. Prefilled Syringes
15.4.3.1.2. Fillable Syringes
15.4.3.1.3. Others
15.5. South America Injectable Drug Delivery Market Value Share Analysis, by End User
15.6. South America Injectable Drug Delivery Market Forecast, by End User
15.6.1. Home Care
15.6.2. Hospital
15.6.3. Ambulatory Care
15.6.4. Physician Offices or Clinics
15.6.5. Others
15.7. South America Injectable Drug Delivery Market Value Share Analysis, by Application
15.8. South America Injectable Drug Delivery Market Forecast, by Application
15.8.1.1. Autoimmune Diseases
15.8.1.2. Oncology Disorders
15.8.1.3. Hormonal Disorders
15.8.1.4. Orphan Diseases
15.8.1.5. Others
15.9. South America Injectable Drug Delivery Market Value Share Analysis, by Country
15.10. South America Injectable Drug Delivery Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Injectable Drug Delivery Market Analysis, by Country
15.12. Brazil Injectable Drug Delivery Market Forecast, by Type
15.12.1. Formulation
15.12.1.1. Conventional Drug Delivery
15.12.1.1.1. Suspensions
15.12.1.1.2. Solutions
15.12.1.1.3. Lyophilized Formulations
15.12.1.1.4. Emulsions
15.12.1.2. Novel Drug Delivery
15.12.1.2.1. Long Acting Injection Formulation
15.12.1.2.2. Microparticles
15.12.1.2.3. Colloidal Dispersions
15.12.1.3. Others
15.12.2. Devices
15.12.2.1. Self-Injection Devices
15.12.2.1.1. Needle-Free Injectors (NFI)
15.12.2.1.2. Wearable Injectors
15.12.2.1.3. Pen Injectors
15.12.2.1.4. Auto-Injectors
15.12.2.1.5. Others
15.12.3. Conventional Injection Devices
15.12.3.1.1. Prefilled Syringes
15.12.3.1.2. Fillable Syringes
15.12.3.1.3. Others
15.13. Brazil Injectable Drug Delivery Market Forecast, by End User
15.13.1. Home Care
15.13.2. Hospital
15.13.3. Ambulatory Care
15.13.4. Physician Offices or Clinics
15.13.5. Others
15.14. Brazil Injectable Drug Delivery Market Forecast, by Application
15.14.1.1. Autoimmune Diseases
15.14.1.2. Oncology Disorders
15.14.1.3. Hormonal Disorders
15.14.1.4. Orphan Diseases
15.14.1.5. Others
15.15. Mexico Injectable Drug Delivery Market Forecast, by Type
15.15.1. Formulation
15.15.1.1. Conventional Drug Delivery
15.15.1.1.1. Suspensions
15.15.1.1.2. Solutions
15.15.1.1.3. Lyophilized Formulations
15.15.1.1.4. Emulsions
15.15.1.2. Novel Drug Delivery
15.15.1.2.1. Long Acting Injection Formulation
15.15.1.2.2. Microparticles
15.15.1.2.3. Colloidal Dispersions
15.15.1.3. Others
15.15.2. Devices
15.15.2.1. Self-Injection Devices
15.15.2.1.1. Needle-Free Injectors (NFI)
15.15.2.1.2. Wearable Injectors
15.15.2.1.3. Pen Injectors
15.15.2.1.4. Auto-Injectors
15.15.2.1.5. Others
15.15.3. Conventional Injection Devices
15.15.3.1.1. Prefilled Syringes
15.15.3.1.2. Fillable Syringes
15.15.3.1.3. Others
15.16. Mexico Injectable Drug Delivery Market Forecast, by End User
15.16.1. Home Care
15.16.2. Hospital
15.16.3. Ambulatory Care
15.16.4. Physician Offices or Clinics
15.16.5. Others
15.17. Mexico Injectable Drug Delivery Market Forecast, by Application
15.17.1.1. Autoimmune Diseases
15.17.1.2. Oncology Disorders
15.17.1.3. Hormonal Disorders
15.17.1.4. Orphan Diseases
15.17.1.5. Others
15.18. Rest of South America Injectable Drug Delivery Market Forecast, by Type
15.18.1. Formulation
15.18.1.1. Conventional Drug Delivery
15.18.1.1.1. Suspensions
15.18.1.1.2. Solutions
15.18.1.1.3. Lyophilized Formulations
15.18.1.1.4. Emulsions
15.18.1.2. Novel Drug Delivery
15.18.1.2.1. Long Acting Injection Formulation
15.18.1.2.2. Microparticles
15.18.1.2.3. Colloidal Dispersions
15.18.1.3. Others
15.18.2. Devices
15.18.2.1. Self-Injection Devices
15.18.2.1.1. Needle-Free Injectors (NFI)
15.18.2.1.2. Wearable Injectors
15.18.2.1.3. Pen Injectors
15.18.2.1.4. Auto-Injectors
15.18.2.1.5. Others
15.18.3. Conventional Injection Devices
15.18.3.1.1. Prefilled Syringes
15.18.3.1.2. Fillable Syringes
15.18.3.1.3. Others
15.19. Rest of South America Injectable Drug Delivery Market Forecast, by End User
15.19.1. Home Care
15.19.2. Hospital
15.19.3. Ambulatory Care
15.19.4. Physician Offices or Clinics
15.19.5. Others
15.20. Rest of South America Injectable Drug Delivery Market Forecast, by Application
15.20.1.1. Autoimmune Diseases
15.20.1.2. Oncology Disorders
15.20.1.3. Hormonal Disorders
15.20.1.4. Orphan Diseases
15.20.1.5. Others
15.21. South America Injectable Drug Delivery Market Attractiveness Analysis
15.21.1. By Type
15.21.2. By End User
15.21.3. By Application
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Baxter International, Inc.,
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Becton Dickinson and Company,
16.3.3. Gerresheimer AG,
16.3.4. Pfizer, Inc.,
16.3.5. Schott AG,
16.3.6. Alkermes Plc.,
16.3.7. Eli Lilly and Company,
16.3.8. Sandoz,
16.3.9. Terumo Corporation,
16.3.10. Teva Pharmaceuticals Industries Ltd.
16.3.11. Ypsomed,
16.3.12. Bespak
16.3.13. Unilife Corporation
16.3.14. Vetter Pharma-Fertigung GmbH & Co. KG
16.3.15. BD
16.3.16. SHL Medical AG
16.3.17. West Pharmaceutical Services, Inc.
16.3.18. Insulate Corporation
16.3.19. Elcam Medical
16.3.20. B. Braun Melsungen
16.3.21. Mylan N.V.
16.3.22. Diabnext
16.3.23. Biocon
16.3.24. Antares Pharma
16.3.25. AbbVie Inc.
16.3.26. Diabnext
16.3.27. SiO2 Medical Products

17. Primary Key Insights
  • INQUIRE BEFORE BUYING